Dartmouth Researchers Develop Reproducibility Score for SNPs Associated with Human Disease in GWAS
October 08, 2014
New Model predicts replication rate in genome-wide studies based on SNP characteristics
To reduce false positives when identifying genetic variations associated with human disease through genome-wide association studies (GWAS), Dartmouth researchers have identified nine traits that are not dependent on P values to predict single nucleotide polymorphisms (SNP) reproducibility as reported in Human Genetics on October 2, 2014.
Reproducibility rates of SNPs based solely on P values is low. Dartmouth authors' analysis of GWAS studies published in Human Genetics showed a 1-5 percent replication rate.
"It is important to improve our ability to select SNPs for validation using a formalized process. In this paper, we propose a combination of traits that improve replication success," said first author Ivan P. Gorlov, PhD, DSC, associate professor of Community and Family Medicine, Geisel School of Medicine at Dartmouth.
The team assigned a value of zero or one to nine different predictors. To compute the Replication Score (RS), one totals the individual scores for all significant predictors. The predictors include "Online Mendelian Inheritance in Man" (OMIM, a list of genetically caused diseases), receptors, kinases, growth factors, transcription factors, tissue specific, plasma membrane localization, nuclear localization and conversation index. The authors provided detailed information to construct the RS in supplementary material to the paper.
An RS score is not disease specific but shows the potential for impact on human disease. "The disease-associated genes have something in common," said Gorlov. "And we know what specific characteristics should be present to ensure the SNP is likely to be replicated."
Gorlov says the empirical model can be used to select SNPs for validation and prioritization. "We believe that RS-based SNP prioritization may provide guidance for more targeted and powered approach to detecting the disease-associated SNPs with small effect size," he concluded.
This work was supported in part by the National Institutes of Health U19 CA148127 Grant and the National Institutes of Health Grants 5 P30 CA016672, LM009012, LM010098 and GM103534. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
About Norris Cotton Cancer Center at Dartmouth-Hitchcock
Norris Cotton Cancer Center combines advanced cancer research at Dartmouth and the Geisel School of Medicine with patient-centered cancer care provided at Dartmouth-Hitchcock Medical Center, at Dartmouth-Hitchcock regional locations in Manchester, Nashua, and Keene, NH, and St. Johnsbury, VT, and at 12 partner hospitals throughout New Hampshire and Vermont. It is one of 41 centers nationwide to earn the National Cancer Institute's "Comprehensive Cancer Center" designation. Learn more about Norris Cotton Cancer Center research, programs, and clinical trials online at cancer.dartmouth.edu.